Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Death Dis ; 5: e1398, 2014 Aug 28.
Article in English | MEDLINE | ID: mdl-25165884

ABSTRACT

Targeting the actin cytoskeleton (CSK) of cancer cells offers a valuable strategy in cancer therapy. There are a number of natural compounds that interfere with the actin CSK, but the mode of their cytotoxic action and, moreover, their tumor-specific mechanisms are quite elusive. We used the myxobacterial compound Chondramide as a tool to first elucidate the mechanisms of cytotoxicity of actin targeting in breast cancer cells (MCF7, MDA-MB-231). Chondramide inhibits cellular actin filament dynamics shown by a fluorescence-based analysis (fluorescence recovery after photobleaching (FRAP)) and leads to apoptosis characterized by phosphatidylserine exposure, release of cytochrome C from mitochondria and finally activation of caspases. Chondramide enhances the occurrence of mitochondrial permeability transition (MPT) by affecting known MPT modulators: Hexokinase II bound to the voltage-dependent anion channel (VDAC) translocated from the outer mitochondrial membrane to the cytosol and the proapoptotic protein Bad were recruited to the mitochondria. Importantly, protein kinase C-ɛ (PKCɛ), a prosurvival kinase possessing an actin-binding site and known to regulate the hexokinase/VDAC interaction as well as Bad phosphorylation was identified as the link between actin CSK and apoptosis induction. PKCɛ, which was found overexpressed in breast cancer cells, accumulated in actin bundles induced by Chondramide and lost its activity. Our second goal was to characterize the potential tumor-specific action of actin-binding agents. As the nontumor breast epithelial cell line MCF-10A in fact shows resistance to Chondramide-induced apoptosis and notably express low level of PKCɛ, we suggest that trapping PKCɛ via Chondramide-induced actin hyperpolymerization displays tumor cell specificity. Our work provides a link between targeting the ubiquitously occurring actin CSK and selective inhibition of pro-tumorigenic PKCɛ, thus setting the stage for actin-stabilizing agents as innovative cancer drugs. This is moreover supported by the in vivo efficacy of Chondramide triggered by abrogation of PKCɛ signaling shown in a xenograft breast cancer model.


Subject(s)
Actin Cytoskeleton/metabolism , Actins/metabolism , Protein Kinase C/metabolism , Actin Cytoskeleton/drug effects , Actins/genetics , Animals , Antineoplastic Agents/therapeutic use , Antineoplastic Agents/toxicity , Apoptosis/drug effects , Binding Sites , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Cytochromes c/metabolism , Depsipeptides/therapeutic use , Depsipeptides/toxicity , Female , Fluorescence Recovery After Photobleaching , Hexokinase/metabolism , Humans , MCF-7 Cells , Membrane Potential, Mitochondrial/drug effects , Mice , Mice, SCID , Mitochondria/metabolism , Phosphatidylserines/pharmacology , Signal Transduction , Transplantation, Heterologous , Voltage-Dependent Anion Channels/metabolism , bcl-Associated Death Protein/metabolism
2.
Cell Death Dis ; 5: e999, 2014 Jan 16.
Article in English | MEDLINE | ID: mdl-24434522

ABSTRACT

Small-conductance Ca(2+)-activated K(+) channel activation is an emerging therapeutic approach for treatment of neurological diseases, including stroke, amyotrophic lateral sclerosis and schizophrenia. Our previous studies showed that activation of SK channels exerted neuroprotective effects through inhibition of NMDAR-mediated excitotoxicity. In this study, we tested the therapeutic potential of SK channel activation of NS309 (25 µM) in cultured human postmitotic dopaminergic neurons in vitro conditionally immortalized and differentiated from human fetal mesencephalic cells. Quantitative RT-PCR and western blotting analysis showed that differentiated dopaminergic neurons expressed low levels of SK2 channels and high levels of SK1 and SK3 channels. Further, protein analysis of subcellular fractions revealed expression of SK2 channel subtype in mitochondrial-enriched fraction. Mitochondrial complex I inhibitor rotenone (0.5 µM) disrupted the dendritic network of human dopaminergic neurons and induced neuronal death. SK channel activation reduced mitochondrial membrane potential, while it preserved the dendritic network, cell viability and ATP levels after rotenone challenge. Mitochondrial dysfunction and delayed dopaminergic cell death were prevented by increasing and/or stabilizing SK channel activity. Overall, our findings show that activation of SK channels provides protective effects in human dopaminergic neurons, likely via activation of both membrane and mitochondrial SK channels. Thus, SK channels are promising therapeutic targets for neurodegenerative disorders such as Parkinson's disease, where dopaminergic cell loss is associated with progression of the disease.


Subject(s)
Dopaminergic Neurons/metabolism , Neuroprotective Agents/metabolism , Parkinson Disease/metabolism , Small-Conductance Calcium-Activated Potassium Channels/metabolism , Calcium/metabolism , Cell Differentiation , Dopaminergic Neurons/cytology , Humans , Membrane Potential, Mitochondrial , Mitochondrial Membranes/metabolism , Parkinson Disease/genetics , Parkinson Disease/physiopathology , Protein Transport , Small-Conductance Calcium-Activated Potassium Channels/genetics
4.
EMBO J ; 18(15): 4241-9, 1999 Aug 02.
Article in English | MEDLINE | ID: mdl-10428962

ABSTRACT

Dictyostelium responds to hyperosmotic stress of 400 mOsm by a rapid reduction of its cell volume to 50%. The reduced cell volume is maintained as long as these osmotic conditions prevail. Dictyostelium does not accumulate compatible osmolytes to counteract the osmotic pressure applied. Using two-dimensional gel electrophoresis, we demonstrate that during the osmotic shock the protein pattern remains unaltered in whole-cell extracts. However, when cells were fractionated into membrane and cytoskeletal fractions, alterations of specific proteins could be demonstrated. In the crude membrane fraction, a 3-fold increase in the amount of protein was measured upon hyperosmotic stress. In the cytoskeletal fraction, the proteins DdLIM and the regulatory myosin light chain (RMLC) were shown to be regulated in the osmotic stress response. The elongation factors eEF1alpha (ABP50) and eEF1beta were found to increase in the cytoskeletal fraction, suggesting a translational arrest upon hyperosmotic stress. Furthermore, the two main components of the cytoskeleton, actin and myosin II, are phosphorylated as a consequence of the osmotic shock, with a tyrosine residue as the phosphorylation site on actin and three threonines in the case of the myosin II heavy chain.


Subject(s)
Dictyostelium/metabolism , Actins/metabolism , Amino Acid Sequence , Animals , Cytoskeletal Proteins/metabolism , Electrophoresis, Gel, Two-Dimensional , Membrane Proteins/metabolism , Molecular Sequence Data , Myosins/metabolism , Osmotic Pressure , Phosphorylation , Ubiquitins/metabolism
5.
Mol Biol Cell ; 9(1): 131-41, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9436996

ABSTRACT

Cdc48p from Saccharomyces cerevisiae and its highly conserved mammalian homologue VCP (valosin-containing protein) are ATPases with essential functions in cell division and homotypic fusion of endoplasmic reticulum vesicles. Both are mainly attached to the endoplasmic reticulum, but relocalize in a cell cycle-dependent manner: Cdc48p enters the nucleus during late G1; VCP aggregates at the centrosome during mitosis. The nuclear import signal sequence of Cdc48p was localized near the amino terminus and its function demonstrated by mutagenesis. The nuclear import is regulated by a cell cycle-dependent phosphorylation of a tyrosine residue near the carboxy terminus. Two-hybrid studies indicate that the phosphorylation results in a conformational change of the protein, exposing the nuclear import signal sequence previously masked by a stretch of acidic residues.


Subject(s)
Cell Cycle Proteins/metabolism , Cell Cycle/physiology , Fungal Proteins/metabolism , Nuclear Localization Signals/physiology , Tyrosine/metabolism , Adenosine Triphosphatases , Amnion/cytology , Cell Cycle Proteins/genetics , Cell Cycle Proteins/physiology , Cell Line , Fungal Proteins/genetics , Fungal Proteins/physiology , Humans , Mutagenesis, Insertional , Nuclear Localization Signals/drug effects , Phosphorylation , Phosphotyrosine/metabolism , Protein Structure, Tertiary , Saccharomyces cerevisiae , Saccharomyces cerevisiae Proteins , Sequence Deletion , Tyrosine/genetics , Valosin Containing Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...